← Leaderboards
Manisha N Patel
National Jewish Health
$19,700,307
Attributed
$21,717,708
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,717,708 · 8
By mechanism
R01$14,010,311 · 4
U01$4,313,565 · 1
R37$2,256,883 · 1
R21$1,136,949 · 2
Top collaborators
- Scott Charles Baraban6 shared
- L Jackson Roberts5 shared
Others in their field
Top investigators on “Oxidative Stress”
- Leonardo Trasande · New York University School Of Medicine$57,471,048
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$36,739,005
- Claire Gmachl · Princeton University$34,397,540
- Akram N Alshawabkeh · Northeastern University$31,872,089
- Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach)$31,629,832
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
Research focus
Oxidative StressSeizuresEpilepsyMitochondriaAntioxidantsBaseBrainMitochondrial DysfunctionLaboratoriesNeuronsReactive Oxygen SpeciesOxidation-ReductionComorbidityChronicPreventImpaired CognitionLeadNeuronal ExcitabilityProductionBioenergeticsMetabolicFunctional DisorderElectroencephalographyGlutathione Disulfide
Grant awards (66)
Mitochondrial Mechanisms of Astrogliosis in Epilesy$535,153
R37 · FY2025 · NS · contact PI
Mitochondrial Mechanisms of Astrogliosis in Epilesy$73,214
R37 · FY2025 · NS · contact PI
Mitochondrial Mechanisms of Astrogliosis in Epilesy$519,097
R37 · FY2024 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$446,692
R01 · FY2024 · HD · contact PI
Mitochondrial Mechanisms of Astrogliosis in Epilesy$72,794
R37 · FY2024 · NS · contact PI
Mitochondrial Mechanisms of Astrogliosis in Epilesy$39,317
R37 · FY2024 · NS · contact PI
Mitochondrial Mechanisms of Astrogliosis in Epilesy$508,654
R37 · FY2023 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$457,317
R01 · FY2023 · HD · contact PI
Mitochondrial Mechanisms of Astrogliosis in Epilesy$508,654
R37 · FY2022 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$463,223
R01 · FY2022 · HD · contact PI
Redox Control of Seizure-Induced Neuroinflammation.$340,156
R01 · FY2022 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$158,867
R01 · FY2022 · HD · contact PI
Redox Control of Seizure-Induced Neuroinflammation.$32,823
R01 · FY2022 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$468,789
R01 · FY2021 · HD · contact PI
Redox Control of Seizure-Induced Neuroinflammation.$340,156
R01 · FY2021 · NS · contact PI
Redox Control of Seizure-Induced Neuroinflammation.$56,268
R01 · FY2021 · NS · contact PI
Redox Control of Seizure-Induced Neuroinflammation$23,445
R01 · FY2021 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$504,392
R01 · FY2020 · HD · contact PI
Redox Control of Seizure-Induced Neuroinflammation.$340,156
R01 · FY2020 · NS · contact PI
Redox Control of Seizure-Induced Neuroinflammation.$340,156
R01 · FY2019 · NS · contact PI
Mitochondrial Sirtuin-3 dysregulation in epileptogenesis$340,156
R01 · FY2019 · NS · contact PI
Mitochondrial Sirtuin-3 dysregulation in epileptogenesis$419,850
R01 · FY2018 · NS · contact PI
Neuroprotective effects of AEOL 10150 against organophosphate toxicity$821,485
U01 · FY2017 · NS · contact PI
Mitochondrial Sirtuin-3 dysregulation in epileptogenesis$419,850
R01 · FY2017 · NS · contact PI
Mitochondrial Sirtuin-3 dysregulation in epileptogenesis$48,202
R01 · FY2017 · NS · contact PI
Neuroprotective effects of AEOL 10150 against organophosphate toxicity$793,984
U01 · FY2016 · NS · contact PI
Gamma-ketoaldehydes in epileptogenesis$341,140
R01 · FY2016 · NS · contact PI
Mitochondrial Sirtuin-3 dysregulation in epileptogenesis$340,156
R01 · FY2016 · NS · contact PI
Neuroprotective effects of AEOL 10150 against organophosphate toxicity$928,345
U01 · FY2015 · NS · contact PI
Gamma-ketoaldehydes in epileptogenesis$341,140
R01 · FY2015 · NS · contact PI
Mitochondrial Sirtuin-3 dysregulation in epileptogenesis$340,156
R01 · FY2015 · NS · contact PI
Neuroprotective effects of AEOL 10150 against organophosphate toxicity$848,415
U01 · FY2014 · NS · contact PI
Gamma-ketoaldehydes in epileptogenesis$337,033
R01 · FY2014 · NS · contact PI
Gamma-ketoaldehydes in epileptogenesis$164,987
R01 · FY2014 · NS · contact PI
Neuroprotective effects of AEOL 10150 against organophosphate toxicity$921,336
U01 · FY2013 · NS · contact PI
Mitochondrial Oxidative Stress in Epileptogenesis$368,795
R01 · FY2013 · NS · contact PI
Gamma-ketoaldehydes in epileptogenesis$351,223
R01 · FY2013 · NS · contact PI
Mitochondrial mechanisms of redox cycling agents$260,335
R01 · FY2013 · NS · contact PI
Mitochondrial Oxidative Stress in Epileptogenesis$381,996
R01 · FY2012 · NS · contact PI
Evaluation of Neuroprotective Effects of AEOL10150 against Chemical Threat Agents$367,761
R21 · FY2012 · NS · contact PI
Mitochondrial mechanisms of redox cycling agents$270,219
R01 · FY2012 · NS · contact PI
Evaluation of Neuroprotective Effects of AEOL10150 against Chemical Threat Agents$68,550
R21 · FY2012 · NS · contact PI
Mitochondrial Oxidative Stress in Epileptogenesis$13,438
R01 · FY2012 · NS · contact PI
Evaluation of Neuroprotective Effects of AEOL10150 against Chemical Threat Agents$368,190
R21 · FY2011 · NS · contact PI
Mitochondrial Oxidative Stress in Epileptogenesis$327,994
R01 · FY2011 · NS · contact PI
Mitochondrial mechanisms of redox cycling agents$270,649
R01 · FY2011 · NS · contact PI
Mitochondrial Oxidative Stress in Epileptogenesis$335,143
R01 · FY2010 · NS · contact PI
Mitochondrial mechanisms of redox cycling agents$249,333
R01 · FY2010 · NS · contact PI
Superoxide Radicals in Seizure-Induced Neuronal Death$99,300
R01 · FY2009 · NS · contact PI
Superoxide Radicals in Seizure-Induced Neuronal Death$354,239
R01 · FY2008 · NS · contact PI
Mitochondrial mechanisms of redox cycling agents$278,208
R01 · FY2008 · NS · contact PI
Mitochondrial Aconitase and Parkinson's Disease$316,691
R01 · FY2007 · NS · contact PI
Superoxide Radicals in Seizure-Induced Neuronal Death$308,247
R01 · FY2007 · NS · contact PI
Two-step therapeutic screen for mitochondrial epilepsies$176,572
R21 · FY2007 · NS · contact PI
Superoxide Radicals in Seizure-Induced Neuronal Death$68,411
R01 · FY2007 · NS · contact PI
Mitochondrial Aconitase and Parkinson's Disease$326,778
R01 · FY2006 · NS · contact PI
Superoxide Radicals in Seizure-Induced Neuronal Death$320,621
R01 · FY2006 · NS · contact PI
Two-step therapeutic screen for mitochondrial epilepsies$155,876
R21 · FY2006 · NS · contact PI
Superoxide Radicals in Seizure-Induced Neuronal Death$338,518
R01 · FY2005 · NS
Mitochondrial Aconitase and Parkinson's Disease$335,268
R01 · FY2005 · NS
Mitochondrial Aconitase and Parkinson's Disease$334,745
R01 · FY2004 · NS
SUPEROXIDE RADICALS IN SEIZURE-INDUCED NEURONAL DEATH$254,500
R01 · FY2003 · NS
SUPEROXIDE RADICALS IN SEIZURE-INDUCED NEURONAL DEATH$226,717
R01 · FY2002 · NS
SUPEROXIDE RADICALS IN SEIZURE-INDUCED NEURONAL DEATH$29,521
R01 · FY2002 · NS
SUPEROXIDE RADICALS IN SEIZURE-INDUCED NEURONAL DEATH$257,852
R01 · FY2001 · NS
SUPEROXIDE RADICALS IN SEIZURE-INDUCED NEURONAL DEATH$266,460
R01 · FY2000 · NS